A61K 2039/5555
Muramyl dipeptides
Official title: {Muramyl dipeptides}
A61K2039/5555 (Muramyl dipeptides) appears on 121 US grants and 98 published applications in this corpus.
Search patents in A61K- Granted patents
- 121
- Published applications
- 98
- Assignees
- 89
- Inventors
- 231
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 3 | 0 |
| 1979 | 3 | 0 |
| 1980 | 4 | 0 |
| 1981 | 2 | 0 |
| 1982 | 2 | 0 |
| 1983 | 2 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 2 | 0 |
| 1988 | 4 | 0 |
| 1989 | 4 | 0 |
| 1990 | 1 | 0 |
| 1991 | 2 | 0 |
| 1992 | 3 | 0 |
| 1993 | 1 | 0 |
| 1994 | 3 | 0 |
| 1995 | 1 | 0 |
| 1996 | 2 | 0 |
| 1997 | 4 | 0 |
| 1998 | 5 | 0 |
| 1999 | 7 | 0 |
| 2000 | 7 | 0 |
| 2001 | 8 | 1 |
| 2002 | 2 | 5 |
| 2003 | 1 | 7 |
| 2004 | 4 | 6 |
| 2005 | 0 | 4 |
| 2006 | 2 | 6 |
| 2007 | 0 | 5 |
| 2008 | 0 | 1 |
| 2009 | 1 | 4 |
| 2010 | 3 | 4 |
| 2011 | 1 | 5 |
| 2012 | 7 | 6 |
| 2013 | 1 | 4 |
| 2014 | 5 | 3 |
| 2015 | 1 | 3 |
| 2016 | 0 | 4 |
| 2017 | 1 | 3 |
| 2018 | 3 | 2 |
| 2019 | 2 | 3 |
| 2020 | 4 | 3 |
| 2021 | 3 | 4 |
| 2022 | 2 | 4 |
| 2023 | 1 | 3 |
| 2024 | 3 | 5 |
| 2025 | 1 | 2 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Use of membrane inhibitors to enhance vaccine development against enveloped viruses8 Sep 2026US 12,728,161 B2Cornell University
- Lipophilic enantiomers of desacetylglucosamine muramyl dipeptide with anti-inflammatory and growth promoting activity9 Dec 2025US 12,492,222 B2Nutrivert LLC
- Muramyl peptide derivatives5 Nov 2024US 12,134,664 B2Bharat Biotech International Limited
- Vaccination with mRNA-coded antigens16 Jul 2024US 12,036,277 B2CureVac AG
- Vaccination with mRNA-coded antigens7 May 2024US 11,975,064 B2CureVac AG
- Adjuvanted immunogenic composition against neisseria meningitidis b19 Feb 2026US 2026/0048113 A1Sanofi Pasteur Limited
- Muramyl dipeptides and process for preparation thereof29 May 2025US 2025/0170237 A1
- Her-1, her-3 and igf-1r compositions and uses thereof20 Feb 2025US 2025/0059256 A1Ohio State Innovation Foundation
- Nematode vaccine5 Dec 2024US 2024/0398915 A1AgResearch Limited
- Vaccination in elderly patients28 Nov 2024US 2024/0390478 A1CureVac AG
Most cited
By later US patents
- Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant395US 6,406,705 B1Coley Pharmaceutical GmbH · 2002
- Vaccine containing tumor antigens and adjuvants126US 4,877,611 ARibi ImmunoChem Research, Inc. · 1989
- Vaccine compositions containing liposomes86US 5,709,879 AChiron Corporation · 1998
- Antigenic modification of polypeptides83US 4,302,386 AThe Ohio State University · 1981
- Method of inducing an antigen-specific immune response by administering a synergistic combination of adjuvants comprising unmethylated CpG-containing nucleic acids and a non-nucleic acid adjuvant67US 7,488,490 B2University of Iowa Research Foundation · 2009